Raymond James & Associates Grifols Sa Put Options Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GRFS
# of Institutions
150Shares Held
140MCall Options Held
3.54MPut Options Held
919K-
Capital World Investors Los Angeles, CA20.7MShares$135 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA17.1MShares$112 Million1.53% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$93.6 Million0.04% of portfolio
-
Permian Investment Partners, LP New York, NY12.8MShares$83.7 Million11.07% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.5MShares$74.7 Million2.32% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.43B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...